<DOC>
	<DOCNO>NCT01257971</DOCNO>
	<brief_summary>This multi-centre non-interventional study patient treat HMGCoA reductase inhibitor available Croatia ( rosuvastatin , simvastatin , atorvastatin fluvastatin ) least 6 month . All HMG-CoA reductase inhibitor must prescribe accordance SmPCs approve Croatia . Data collection patient take place single visit . The investigator complete Case Report Form patient 's demographic , presence factor high cardiovascular risk , current treatment , cholesterol value well treatment decision .</brief_summary>
	<brief_title>Non-interventional Study ( NIS ) Assess Reaching Cholesterol Target Values Patients Treated With HMG-CoA Reductase Inhibitors</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
	<criteria>patient treat one HMGCoA reductase inhibitor least 6 month without change dose last 4 week least . All patient must sign Informed consent form . Patients sign Informed consent form . Patients contraindication treatment HMGCoA reductase inhibitor per SmPC approve Croatia .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Cholesterol</keyword>
	<keyword>HMG-CoA reductase inhibitor</keyword>
	<keyword>cardiovascular risk</keyword>
	<keyword>LDLl</keyword>
</DOC>